J. Brazier

C. von Eichel-Streiber, J. Brazier, S. Borgmann, 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Clostridium di facile: An update on its epidemiology and role in hospital outbreaks in England and Wales

J. Brazier, P. Wall, T. Djuretic, 1999 .

Distribution and antimicrobial susceptibility patterns of Clostridium difficile PCR ribotypes in English hospitals, 2007-08.

A. Charlett, G. Duckworth, A. Pearson, 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Prevalence and association of PCR ribotypes of Clostridium difficile isolated from symptomatic patients from Warsaw with macrolide-lincosamide-streptogramin B (MLSB) type resistance.

M. Luczak, J. Brazier, F. Meisel-Mikołajczyk, 2006, Journal of medical microbiology.

Production of actin-speci¢c ADP-ribosyltransferase (binary toxin) by strains of Clostridium di⁄cile

M. Rupnik, M. Gibert, J. Brazier, 2000 .

Comparison of toxinotyping and PCR ribotyping of Clostridium difficile strains and description of novel toxinotypes.

M. Rupnik, J. Brazier, B. Duerden, 2001, Microbiology.

International typing study of Clostridium difficile.

D. Gerding, Stuart Johnson, T. Riley, 2014, Anaerobe.

Clostridium difficile infection among immunocompromised patients in Rio de Janeiro, Brazil and detection of moxifloxacin resistance in a ribotype 014 strain.

L. Lobo, R. Domingues, J. Brazier, 2014, Anaerobe.

First isolation of Clostridium difficile PCR ribotype 027 from a patient with severe persistent diarrhoea in Hungary.

E. Kuijper, E. Urbán, J. Brazier, 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Characterization of Clostridium difficile strains isolated from immunosuppressed inpatients in a hospital in Rio de Janeiro, Brazil.

R. Domingues, J. Brazier, K. R. Miranda, 2009, Anaerobe.

Equine Colitis X Associated with Infection by Clostridium Difficile NAP1/027

J. Songer, J. Brazier, Hien T. Trinh, 2009, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

Essential role of toxin A in C. difficile 027 and reference strain supernatant‐mediated disruption of Caco‐2 intestinal epithelial barrier function

J. Brazier, Y. Mahida, P. Sutton, 2008, Clinical and experimental immunology.

Molecular characterization and antimicrobial susceptibility patterns of Clostridium difficile strains isolated from hospitals in south-east Scotland.

J. Brazier, I. Poxton, Esvet Mutlu, 2007, Journal of medical microbiology.

New PCR ribotypes of Clostridium difficile detected in children in Brazil

R. Domingues, J. Brazier, K. R. Miranda, 2007, Antonie van Leeuwenhoek.

Comparative Phylogenomics of Clostridium difficile Reveals Clade Specificity and Microevolution of Hypervirulent Strains

A. Witney, D. Gerding, J. Hinds, 2006, Journal of bacteriology.

Soft tissue infections caused by spore-forming bacteria in injecting drug users in the United Kingdom

J. Brazier, B. Duerden, M. Brett, 2005, Epidemiology and Infection.

New types of toxin A-negative, toxin B-positive strains among clinical isolates of Clostridium difficile in Australia.

M. Rupnik, T. Riley, J. Brazier, 2011, Journal of medical microbiology.

Distribution of Clostridium difficile PCR ribotypes in regions of Hungary.

E. Urbán, J. Brazier, E. Nagy, 2006, Journal of medical microbiology.

Antimicrobial susceptibility of polymerase chain reaction ribotypes of Clostridium difficile commonly isolated from symptomatic hospital patients in the UK.

J. Brazier, R. John, 2005, The Journal of hospital infection.

A European survey of diagnostic methods and testing protocols for Clostridium difficile.

M. Delmée, P. Mastrantonio, M. Rupnik, 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Modification of a PCR Ribotyping Method for Application as a Routine Typing Scheme forClostridium difficile

J. Brazier, B. Duerden, F. Ogunsola, 1996 .

Detection of cross-infection associated to a Brazilian PCR-ribotype of Clostridium difficile in a university hospital in Rio de Janeiro, Brazil

J. Brazier, S. Nouér, I. Balassiano, 2011, Antonie van Leeuwenhoek.

European surveillance study on antimicrobial susceptibility of Gram-positive anaerobic cocci.

C. Nord, J. Brazier, E. Könönen, 2008, International journal of antimicrobial agents.

Anaerobic sepsis due to multidrug-resistant Bacteroides fragilis: microbiological cure and clinical response with linezolid therapy.

M. Millar, D. Wareham, J. Brazier, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Metronidazole resistance in Bacteroides spp. carrying nim genes and the selection of slow-growing metronidazole-resistant mutants.

J. Brazier, M. Gal, 2004, The Journal of antimicrobial chemotherapy.

Effects of metronidazole and oligofructose on faecal concentrations of sulphate-reducing bacteria and their activity in human volunteers

D. Beard, J. Brazier, S. Lewis, 2005, Scandinavian journal of gastroenterology.

Clostridium difficile: from obscurity to superbug

J. Brazier, 2008, British journal of biomedical science.

The epidemiology and typing of Clostridium difficile.

J. Brazier, 1998, The Journal of antimicrobial chemotherapy.

Real-time PCR investigation into the importance of Fusobacterium necrophorum as a cause of acute pharyngitis in general practice.

N. Brown, J. Brazier, N. Bentley, 2004, Journal of medical microbiology.

A selective medium for Fusobacterium spp.

E. Goldstein, D. Citron, J. Brazier, 1991, The Journal of applied bacteriology.

Screening for carriage and nosocomial acquisition of Clostridium difficile by culture: a study of 284 admissions of elderly patients to six general hospitals in Wales.

P. Rooney, J. Brazier, C. Cefai, 1999, The Journal of hospital infection.

Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease

A. van Belkum, J. Brazier, G. Młynarczyk, 2010, European Journal of Clinical Microbiology & Infectious Diseases.

International Typing Study of Toxin A-Negative, Toxin B-Positive Clostridium difficile Variants

M. Delmée, D. Gerding, S. Sambol, 2003, Journal of Clinical Microbiology.

Microbiology, epidemiology and diagnosis of Clostridium difficile infection.

S. Borriello, J. Brazier, 2000, Current topics in microbiology and immunology.

Comparison of alcohol shock enrichment and selective enrichment for the isolation of Clostridium difficile

K. Phillips, T. Riley, J. Brazier, 1987, Epidemiology and Infection.

An outbreak case of Clostridium difficile-associated diarrhea among elderly inpatients of an intensive care unit of a tertiary hospital in Rio de Janeiro, Brazil.

J. Brazier, A. Japiassú, M. Ramos, 2010, Diagnostic microbiology and infectious disease.

Application of multiple-locus variable-number tandem-repeat analysis to determine clonal spread of toxin A-negative Clostridium difficile in a general hospital in Buenos Aires, Argentina.

E. Kuijper, A. Goorhuis, J. Brazier, 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Prevalent PCR ribotypes of clinical and environmental strains of Clostridium difficile isolated from intensive-therapy unit patients in Kuwait.

J. Brazier, E. Mokaddas, W. Jamal, 2003, Journal of medical microbiology.

Reduced susceptibility of Clostridium difficile to metronidazole.

M. Wilcox, J. Brazier, W. Fawley, 2001, The Journal of antimicrobial chemotherapy.

Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe.

M. Delmée, E. Kuijper, P. Mastrantonio, 2008, Journal of medical microbiology.

A note on ultra-violet red fluorescence of anaerobic bacteria in vitro.

J. Brazier, 1986, The Journal of applied bacteriology.

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

Jon Brazier, Eric Frost, L. McDonald, 2005, The Lancet.

Clostridium difficile: the anaerobe that made the grade.

J. Brazier, 2012, Anaerobe.

Epidemic Strains of Clostridium difficile: REA, PFGE, PCR-

C. Woods, P. Savelkoul, D. Gerding, 2007 .

Emergence and global spread of epidemic healthcare-associated Clostridium difficile

M. Pirmohamed, G. Dougan, J. Parkhill, 2012, Nature Genetics.

An outbreak of serious illness and death among injecting drug users in England during 2000.

J. McLauchlin, J. Salmon, G. Nichols, 2002, Journal of medical microbiology.

Fusobacterium necrophorum infections in England and Wales 1990-2000.

J. Brazier, B. Duerden, E. Yusuf, 2002, Journal of medical microbiology.

Molecular investigation of genetic elements contributing to metronidazole resistance in Bacteroides strains.

E. Urbán, V. Rotimi, J. Brazier, 2006, The Journal of antimicrobial chemotherapy.

Human infections with Fusobacterium necrophorum.

J. Brazier, 2006, Anaerobe.

Fusobacterium necrophorum infections in man

J. Brazier, 2002 .

Antibiotic susceptibility of clinical isolates of clostridia.

K. Phillips, J. Brazier, P. Levett, 1985, The Journal of antimicrobial chemotherapy.

Fastidious anaerobe agar compared with Wilkins-Chalgren agar, brain heart infusion agar, and brucella agar for susceptibility testing of Fusobacterium species

E. Goldstein, D. Citron, J. Brazier, 1990, Antimicrobial Agents and Chemotherapy.

Heterogeneity within the gram-positive anaerobic cocci demonstrated by analysis of 16S-23S intergenic ribosomal RNA polymorphisms.

M. Lewis, J. Brazier, K. E. Hill, 2002, Journal of medical microbiology.

Metronidazole resistance among clinical isolates belonging to the Bacteroides fragilis group: time to be concerned?

J. Brazier, B. Duerden, S. Stubbs, 1999, The Journal of antimicrobial chemotherapy.

Heat and acid tolerance of Clostridium novyi Type A spores and their survival prior to preparation of heroin for injection.

J. Brazier, B. Duerden, T. E. Morris, 2003, Anaerobe.

Propionibacterium propionicum and infections of the lacrimal apparatus.

J. Brazier, J S Brazier, V Hall, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile.

M. Rupnik, M. Gibert, M. Popoff, 2000, FEMS microbiology letters.

A comparative study of Fusobacterium necrophorum strains from human and animal sources by phenotypic reactions, pyrolysis mass spectrometry and SDS-PAGE.

J. Brazier, B. Duerden, H. Ryley, 1997, Journal of medical microbiology.

PCR-Restriction Fragment Length Polymorphism Analysis for Identification of Bacteroides spp. and Characterization of Nitroimidazole Resistance Genes

P. Talbot, J. Brazier, B. Duerden, 2000, Journal of Clinical Microbiology.

Identification of Bacteroides and Actinomyces by 16S rDNA PCR-restriction Fragment Length Polymorphism

P. Talbot, J. Brazier, B. Duerden, 2000 .

E. Goldstein, D. Citron, J. Brazier, 1995, Journal of clinical microbiology.

A study of infectious intestinal disease in England: microbiological findings in cases and controls.

H R Smith, P Cumberland, D. Tompkins, 1999, Communicable disease and public health.

Prevalence of PCR Ribotypes among Clostridium difficile Isolates from Pigs, Calves, and Other Species

S. Weese, J. Songer, J. Brazier, 2007, Journal of Clinical Microbiology.

Optimal methods for identifying Clostridium difficile infections.

D. Gerding, J. Brazier, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Subtyping of Clostridium difficile polymerase chain reaction (PCR) ribotype 001 by repetitive extragenic palindromic PCR genomic fingerprinting.

J. Brazier, G. Northey, A. Rahmati, 2005, The Journal of hospital infection.

TYPING OF FUSOBACTERIUM NECROPHORUM STRAINS USING POLYMERASE CHAIN REACTION (PCR) BASED METHODS

J. Brazier, A. Rahmati, 2016 .

Amplified fragment length polymorphism (AFLP) analysis of Clostridium novyi, C. perfringens and Bacillus cereus isolated from injecting drug users during 2000.

J. McLauchlin, J. Salmon, R. George, 2002, Journal of medical microbiology.

Coincidence of bft and cfiA genes in a multi-resistant clinical isolate of Bacteroides fragilis.

E. Urbán, J. Brazier, E. Nagy, 2007, Journal of medical microbiology.

Isolation and identification of Clostridium spp. from infections associated with the injection of drugs: experiences of a microbiological investigation team.

J. McLauchlin, J. Salmon, R. George, 2002, Journal of medical microbiology.

Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008.

J. Mossong, M. Delmée, T. Eckmanns, 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Genetic analysis of mechanisms of multidrug resistance in a clinical isolate of Bacteroides fragilis.

D. Wareham, J. Brazier, H. Wexler, 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates.

M. Delmée, E. Kuijper, P. Mastrantonio, 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Clostridium difficile infection in Europe: a hospital-based survey

E. Kuijper, M. Wilcox, M. Rupnik, 2011, The Lancet.

PCR Targeted to the 16S-23S rRNA Gene Intergenic Spacer Region ofClostridium difficile and Construction of a Library Consisting of 116 Different PCR Ribotypes

J. Brazier, B. Duerden, G. O'neill, 1999, Journal of Clinical Microbiology.

Analysis of prevalence, risk factors and molecular epidemiology of Clostridium difficile infection in Kuwait over a 3-year period.

V. Rotimi, J. Brazier, W. Jamal, 2010, Anaerobe.

Typing of Clostridium difficile.

J. Brazier, Jon S. Brazier, 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

The diagnosis of Clostridium difficile-associated disease.

J. Brazier, 1998, The Journal of antimicrobial chemotherapy.

Role of the laboratory in investigations of Clostridium difficile diarrhea.

J. Brazier, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Correlation of Multidrug Resistance, Toxinotypes and PCR Ribotypes in Clostridium difficile Isolates from Kuwait

M. Rupnik, J. Brazier, V. Rotimi, 2009, Journal of chemotherapy.

contamination of public tap water distribution system during a waterborne outbreak in Clostridium difficile

I. Miettinen, T. Pitkänen, M. Kuusi, 2013 .

Comparison of molecular typing methods applied to Clostridium difficile.

E. Kuijper, J. Brazier, R. J. van den Berg, 2009, Methods in molecular biology.

Prevalence of toxin A negative/B positive Clostridium difficile strains.

J. Brazier, B. Duerden, S. Stubbs, 1999, The Journal of hospital infection.

Preliminary findings of the international typing study on Clostridium difficile. International Clostridium Difficile Study Group.

M. Delmée, M. Mulligan, J. Brazier, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

An investigation of a nosocomial outbreak of Clostridium difficile by pyrolysis mass spectrometry.

J. Brazier, B. Duerden, A. J. Sinclair, 1993, Journal of medical microbiology.

Guidelines for optimal surveillance of Clostridium difficile infection in hospitals.

J. Brazier, B. Duerden, 1998, Communicable disease and public health.

PCR-ribotyping and pyrolysis mass spectrometry fingerprinting of environmental and hospital isolates of Clostridium difficile.

J. Brazier, B. Duerden, G. O'neill, 1998, Journal of medical microbiology.

Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe.

F Allerberger, C. Suetens, M. Delmée, 2007, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

PCR ribotyping of clinically important Clostridium difficile strains from Hungary.

E. Urbán, J. Brazier, E. Nagy, 2001, Journal of medical microbiology.

Extended Multilocus Variable-Number Tandem-Repeat Analysis of Clostridium difficile Correlates Exactly with Ribotyping and Enables Identification of Hospital Transmission

J. Brazier, P. Hawkey, K. Hardy, 2011, Journal of Clinical Microbiology.

Ultra-violet fluorescence of Clostridium perfringens

J. Brazier, 1984 .

Evaluation of a commercial enzyme immunoassay kit for the detection ofClostridium difficile toxin A

S. Borriello, J. Brazier, S. Hyde, 1992, European Journal of Clinical Microbiology and Infectious Diseases.

Clinical Severity of Clostridium difficile PCR Ribotype 027: A Case-Case Study

N. Verlander, J. Brazier, Derek F. J. Brown, 2008, PloS one.

Distribution of Clostridium difficile PCR ribotype 027 in British hospitals.

A. Pearson, J. Brazier, B. Patel, 2007, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Clostridium difficile: an update on its epidemiology and role in hospital outbreaks in England and Wales.

J. Brazier, P. Wall, T. Djuretic, 1999, The Journal of hospital infection.

lktA-encoded leukotoxin is not a universal virulence factor in invasive Fusobacterium necrophorum infections in animals and man.

J. Brazier, M. Curran, H. Ludlam, 2009, Journal of medical microbiology.

Analysis of the porphyrin content of fluorescent pus by absorption spectrophotometry and high performance liquid chromatography.

J. Brazier, 1990, Journal of medical microbiology.

Antibiotic susceptibilities of Gram-positive anaerobic cocci: results of a sentinel study in England and Wales.

J. Brazier, B. Duerden, V. Hall, 2003, The Journal of antimicrobial chemotherapy.

The laboratory diagnosis of Clostridium difficile‐associated disease

J. Brazier, 1995 .

First report of Parabacteroides goldsteinii bacteraemia in a patient with complicated intra-abdominal infection.

E. Goldstein, J. Brazier, P. Patel, 2010, Anaerobe.

Veillonella and Other Anaerobic Gram-Negative Cocci

J. Brazier, 2010 .

Evaluation of the Anoxomat: a new technique for anaerobic and microaerophilic clinical bacteriology.

J. Brazier, S. Smith, J S Brazier, 1989, Journal of clinical pathology.

Tetanus and other clostridial diseases

J. Brazier, B. Duerden, 2001 .

Typing of environmental Clostridium difficile strains.

J. Brazier, B. Duerden, G. O'neill, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evaluation of a phenotypic scheme for identification of the 'butyrate-producing' Peptostreptococcus species.

M. Lewis, J. Brazier, M. Wilson, 2000, Journal of Medical Microbiology.

Molecular Characterization of Nitroimidazole Resistance in Metronidazole-Resistant Bacteroides Species Isolated from Hospital Patients in Kuwait

J. Brazier, W. Jamal, M. Johny, 2004, Medical Principles and Practice.

Bacteroides species highly resistant to metronidazole: an emerging clinical problem?

V. Rotimi, J. Brazier, W. Jamal, 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Prevalence and characterization of nim genes of Bacteroides spp. isolated in Hungary

E. Urbán, J. Brazier, E. Nagy, 2002 .

Medical and Environmental Aspects of Anaerobes

J. Brazier, B. Duerden, 1992 .

Failure of dietary oligofructose to prevent antibiotic‐associated diarrhoea

A. Awasthi, A. Awasthi, J. Brazier, 2005, Alimentary pharmacology & therapeutics.

Antimicrobials against Anaerobic Bacteria

J. Brazier, B. Duerden, 2001 .

Polymerase chain reaction ribotypes of Clostridium difficile in hospitals in England and Wales

J. Brazier, B. Duerden, G. OʼNeill, 1997 .

Anaerobic balanoposthitis.

K. Phillips, J. Brazier, A. Willis, 1982, British medical journal.